167 results on '"Mitchell, John M"'
Search Results
2. Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis
3. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users
4. Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects
5. Performance of Hair Testing for Cocaine Use—Comparison of Five Laboratories Using Blind Reference Specimens
6. Performance of Hair Testing for Cocaine Use—Comparison of Five Laboratories Using Blind Reference Specimens.
7. Composition and Stability of a Standard Marihuana Cigarette
8. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products
9. Can the Professor Come Out and Play?—Scholarship, Teaching, and Theories of Play
10. Eye Malformations in Rats: Induction by Prenatal Exposure to Nickel Carbonyl
11. How the Economist Helps Business, Industry and the Investor
12. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration
13. Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC–MS Analysis
14. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
15. Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC–MS Analysis.
16. Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females
17. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis
18. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis
19. Assessment of the stability of DNA in specimens collected under conditions for drug testing—A pilot study
20. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users
21. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid
22. Inhibitory Effect of a Green Tea Polyphenol Fraction on 12-O-Tetradecanoylphorbol-13-acetate-Induced Hydrogen Peroxide Formation in Mouse Epidermis
23. The United States Coast Guard's proposed regulation of certificates of financial responsibility under the Oil Pollution Act of 1990: fostering a continuing market of insurance for shipowners?
24. Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.
25. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.
26. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.
27. Development of a Quantitative LC–MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid
28. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults
29. Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC–MS-MS
30. Carcinogenicity of Nickel Subsulfide in Fischer Rats and Syrian Hamsters after Administration by Various Routes
31. Construction: a Forecast
32. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes
33. Synthesis and investigation of 1,6-bis-di-tert-butylphosphinohexane and its application in Suzuki–Miyaura coupling
34. Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration
35. Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration
36. Pharmacokinetic Characterization of 11-nor-9- carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.
37. Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS.
38. Assessment of the stability of DNA in specimens collected under conditions for drug testing-A pilot study.
39. Will Your Chapter be Ready? When disaster strikes, can your emergency transportation plans be put into effect?
40. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects
41. Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration
42. Non-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results
43. ChemInform Abstract: Synthesis and Investigation of 1,6-Bis-di-tert-butylphosphinohexane and Its Application in Suzuki-Miyaura Coupling.
44. Response to comments on “Morphological changes in human head hair subjected to various drug testing decontamination strategies” by Hill et al.
45. Prescription Opioids. III. Disposition of Oxycodone in Oral Fluid and Blood Following Controlled Single-Dose Administration.
46. Non-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results.
47. Validation of the LacTek Test Applied to Spiked Extracts of Tissue Samples: Determination of Performance Characteristics
48. Roles and Missions for Special Operations Forces in the 1990's
49. The Pharmacology of Physostigmine
50. Right ventricular protection with coronary sinus retrograde cardioplegia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.